Biosimilars – Understanding the Regulatory Challenges

July 16, 2013 8:58 AM

Center for Professional Innovation and Education, Inc. is organizing the Biosimilars – Understanding the Regulatory Challenges in King of Prussia, Pennsylvania on 4-5 November 2013.

Why this conference?
To better understand what the developing FDA biosimilar pathway might look like, this course will closely examine the existing regulatory guidelines from the European Medicine Agency (EMA) and the World Health Organization (WHO), and compare them to the draft FDA guidances. Insights and practical suggestions to help your company enter the biosimilar biological product market will be provided by examining what has worked, and what has not, for the existing market-approved EMA biosimilars and FDA follow-on-proteins.

You can get more information from: http://www.cfpie.com/showitem.aspx?productid=130

 

Would you like to post an event on Biosimilar News?

Leave a Reply

Twitter ID
(ID only. No links or "@" symbols)


Share an Article?

Writing an article is not only a great way to share your knowledge, but it is also a great way to give back to the community.

We value all our contributors and if you have a website, we will surely give a link back to your site and products.
Wanna contribute?

Suggestions?

Biosimilar News was started for the people who are interested in this rapidly growing business area. So if you have suggestions or feedback on how we can improve, please let us know. If you want to see a specific topic covered, answer to a specific question, or anything else of this sort, just write us. We do our best to keep up!
Make a suggestion now!